Advertisement

Reactions Weekly

, Volume 1179, Issue 1, pp 5–5 | Cite as

The EMEA has recommended the suspension of marketing authorisations for all carisoprodol-containing products

Media release
  • 10 Downloads

Keywords

Public Health Marketing Withdrawal Symptom Marketing Authorisation CHMP 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

REFERENCE

  1. 1.
    EMEA.European Medicines Agency recommends suspension of marketing authorisations for carisoprodol-containing medicinal products. Media Release: 16 Nov 2007. Available from: URL: http://www.emea.europe.eu

Copyright information

© Adis International limited or Adis Data Information BV 2007

Personalised recommendations